Clinton Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $241K | Buy |
+1,789
| New | +$241K | 0.09% | 167 |
|
|
2017
Q4 | – | Sell |
-5,409
| Closed | -$584K | – | 411 |
|
|
2017
Q3 | $584K | Buy |
+5,409
| New | +$584K | 0.06% | 272 |
|
|
2017
Q2 | – | Sell |
-8,458
| Closed | -$761K | – | 623 |
|
|
2017
Q1 | $761K | Buy |
8,458
+335
| +4% | +$30.1K | 0.04% | 492 |
|
|
2016
Q4 | $619K | Sell |
8,123
-34,221
| -81% | -$2.61M | 0.04% | 515 |
|
|
2016
Q3 | $3.53M | Buy |
42,344
+6,089
| +17% | +$507K | 0.17% | 189 |
|
|
2016
Q2 | $2.99M | Buy |
36,255
+1,774
| +5% | +$146K | 0.13% | 211 |
|
|
2016
Q1 | $2.62M | Buy |
+34,481
| New | +$2.62M | 0.16% | 190 |
|
|
2015
Q3 | – | Sell |
-8,411
| Closed | -$592K | – | 697 |
|
|
2015
Q2 | $592K | Buy |
8,411
+3,649
| +77% | +$257K | 0.08% | 346 |
|
|
2015
Q1 | $378K | Buy |
+4,762
| New | +$378K | 0.1% | 306 |
|